You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 11, March 21, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Urinary Tract Disorders
 •Men's Health, Other
 •Alert me on articles by topic

Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Kaplan and colleagues1 assessed the efficacy of tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. We are concerned about 2 issues that may have had an effect on the observed efficacy and tolerability of the evaluated treatments.

First, there was no mention of adrenergic agonists or drugs with adverse anticholinergic effects in the list of excluded medical treatments. Adrenergic agonists, particularly those that possess activity at the {alpha}-1 receptor—such as pseudoephedrine, ephedrine, and phenylephrine—can exacerbate the symptoms of BPH.2 Use of an {alpha}-1 agonist would also be expected to decrease the response to tamsulosin due to competitive inhibition at the receptor. In addition, first-generation antihistamines—such as chlorpheniramine and diphenhydramine—cause adverse anticholinergic effects and can be associated with urinary difficulties in men with a history of prostate problems.3 If the exclusion criteria of antimuscarinic agents included antihistamines, it was not . . . [Full Text of this Article]

William Andrew Bell, BS
wbell@utmem.edu

Naseem Amarshi, MSc, PharmD
University of Tennessee College of Pharmacy
Memphis


RELATED LETTERS

Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder
Toby C. Chai
JAMA. 2007;297(11):1191-1192.
EXTRACT | FULL TEXT  

Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder
James G. Young and Kesavapilla Subramonian
JAMA. 2007;297(11):1192-1193.
EXTRACT | FULL TEXT  

Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder—Reply
Steven A. Kaplan, Claus G. Roehrborn, Eric S. Rovner, Tamara Bavendam, and Zhonghong Guan
JAMA. 2007;297(11):1193.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.